{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-02-08T12:28:14.356925+00:00",
  "news": [
    {
      "title": "Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report - Amgen",
      "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNa1A1XzhsX21GQmMxVWNQQWlKSmFsN0d2Zk1saTI4al9sZW1WODJmMFZpMWpRQ1QzbE1qSjZieTU4WEFMblBSeEQxekZjSkZFQm00MmNnVnNhTmlpdmgzYVF3emZBZmptQ2dJVGJnWlh1NFE5TlFreE80SWxjdF8tSUp5enRVenFBMVZrc2lfbnRFLXJDaUV6SzlrcVU1M292TW9kVlFsajBmU0lhdElR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxNa1A1XzhsX21GQmMxVWNQQWlKSmFsN0d2Zk1saTI4al9sZW1WODJmMFZpMWpRQ1QzbE1qSjZieTU4WEFMblBSeEQxekZjSkZFQm00MmNnVnNhTmlpdmgzYVF3emZBZmptQ2dJVGJnWlh1NFE5TlFreE80SWxjdF8tSUp5enRVenFBMVZrc2lfbnRFLXJDaUV6SzlrcVU1M292TW9kVlFsajBmU0lhdElR?oc=5\" target=\"_blank\">Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2026-02-03T21:35:04+00:00",
      "source": "Amgen"
    },
    {
      "title": "AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPbGlPdTREbHB3UXJRZlFydG9zTGQyMnlkeTcwNmpGaTlQdnhiTDJXN1A5SG9VR2R2VWx1cGVpVmJneU9VVzhwVUo1NFc5REswbXV2S2x5cWxrd2dKV19nOTFmNGlERnhTRXhFMVNmWUhVVll0WEFjR2hSajR4T252LXlSTk9rbFhfMHM1NEJiRVFPVHZReUNQbzNKVWZKbTZOV1haQkZNNFZibHZueVRkMHoxLURNVG04bWZ4dllB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxPbGlPdTREbHB3UXJRZlFydG9zTGQyMnlkeTcwNmpGaTlQdnhiTDJXN1A5SG9VR2R2VWx1cGVpVmJneU9VVzhwVUo1NFc5REswbXV2S2x5cWxrd2dKV19nOTFmNGlERnhTRXhFMVNmWUhVVll0WEFjR2hSajR4T252LXlSTk9rbFhfMHM1NEJiRVFPVHZReUNQbzNKVWZKbTZOV1haQkZNNFZibHZueVRkMHoxLURNVG04bWZ4dllB?oc=5\" target=\"_blank\">AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2026-02-03T21:01:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNOXJjVlRweEFDdlFaZUtScWl2UFJkWWVHNzgzWXhkT3BPX2hjWjJqRGhpZVJuOW4tbUdoWlZWQURCcjY2ZndZakh5M2Y4eDhEVWRvb0NnaWkwV1lWbzNaNmxYNElnQXpVLW5fY0xtdXREbWhNa0JZd19JZnVBblNITzdzWnlEbUpLRTU0RkxWV0g3c0NP?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxNOXJjVlRweEFDdlFaZUtScWl2UFJkWWVHNzgzWXhkT3BPX2hjWjJqRGhpZVJuOW4tbUdoWlZWQURCcjY2ZndZakh5M2Y4eDhEVWRvb0NnaWkwV1lWbzNaNmxYNElnQXpVLW5fY0xtdXREbWhNa0JZd19JZnVBblNITzdzWnlEbUpLRTU0RkxWV0g3c0NP?oc=5\" target=\"_blank\">Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2026-02-04T14:59:19+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Amgen Defends Tavneos Benefit-Risk Profile Following FDA Withdrawal Request - Medical Professionals Reference",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNRS1GUXNRaS1jZzMwS0JhcmJTT3JYc01KdjlwbERzU1pQclhqTVpWZHQ4V091V1VfU2N0N0FSV1RBUFkwM0tqS25JUjY3Ukx3ZG9abGQwYXRtckI2Q215ZzBLZkpuTlliVE1GMHRUM1ZsamxOR0FJVmc3WkZ5cFVlR2pTV0RCRkRRdVdfTG95MTZxemFHX2pWQmZFeWN4TjB5eHVpZg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNRS1GUXNRaS1jZzMwS0JhcmJTT3JYc01KdjlwbERzU1pQclhqTVpWZHQ4V091V1VfU2N0N0FSV1RBUFkwM0tqS25JUjY3Ukx3ZG9abGQwYXRtckI2Q215ZzBLZkpuTlliVE1GMHRUM1ZsamxOR0FJVmc3WkZ5cFVlR2pTV0RCRkRRdVdfTG95MTZxemFHX2pWQmZFeWN4TjB5eHVpZg?oc=5\" target=\"_blank\">Amgen Defends Tavneos Benefit-Risk Profile Following FDA Withdrawal Request</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Medical Professionals Reference</font>",
      "published": "2026-02-04T05:00:00+00:00",
      "source": "Medical Professionals Reference"
    },
    {
      "title": "Amgen Q4 results beat Street estimates, company says patients need weight-loss options - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxQSEhLZkpIbUJyQVJwbnZ5MEVNUkF2MDNUYXgwcVpHcEFFM1N6eFJFa1Q4aFAtdGNPczNGbk82N0Q0c2xlMFhwN0ItN3pMTHBzTkJCbVJPX3F2QnIxeVRjakVQalNmNDBzTU9hN1VrSmlEamU0a1dvYkQwcXhVNmVxaDZKa3J0VjhQNHVUWno2a1k5eEVkX1ZycFZDalUwTG9hVVFsbVlITldNdjNCVFlaMk1vdTVZZGJlQ2otZ1RDdkEtdkpCSlZRY2VqQkV0VGpaYkNILXk0dWM2VUJCdnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQSEhLZkpIbUJyQVJwbnZ5MEVNUkF2MDNUYXgwcVpHcEFFM1N6eFJFa1Q4aFAtdGNPczNGbk82N0Q0c2xlMFhwN0ItN3pMTHBzTkJCbVJPX3F2QnIxeVRjakVQalNmNDBzTU9hN1VrSmlEamU0a1dvYkQwcXhVNmVxaDZKa3J0VjhQNHVUWno2a1k5eEVkX1ZycFZDalUwTG9hVVFsbVlITldNdjNCVFlaMk1vdTVZZGJlQ2otZ1RDdkEtdkpCSlZRY2VqQkV0VGpaYkNILXk0dWM2VUJCdnc?oc=5\" target=\"_blank\">Amgen Q4 results beat Street estimates, company says patients need weight-loss options</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2026-02-04T00:44:34+00:00",
      "source": "Reuters"
    },
    {
      "title": "Amgen advances toward lupus redemption while gastric cancer candidate struggles - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxORG16Q0FuaGxrdVdBd0Z6YWN0cHVBVkh5eWE0S1E0WEtKV3RDMXFpZC12WkFmS0M0SjRlWkNJY2NCWlRQMmNXNncydU5nZVlSZ1dFNXdteUpyaU1mQnF0OV9tUVE0YURRZmpFTGNTYnE0OUoyZl9sN2dHa1pQeWRmX3Z0Y3NYUVc4VERsMkhHd1MxYXp3bEppZ2ptVklOclhDZTVISFpwYUt3X0xzbnBPMlAyQVhTN0U2?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxORG16Q0FuaGxrdVdBd0Z6YWN0cHVBVkh5eWE0S1E0WEtKV3RDMXFpZC12WkFmS0M0SjRlWkNJY2NCWlRQMmNXNncydU5nZVlSZ1dFNXdteUpyaU1mQnF0OV9tUVE0YURRZmpFTGNTYnE0OUoyZl9sN2dHa1pQeWRmX3Z0Y3NYUVc4VERsMkhHd1MxYXp3bEppZ2ptVklOclhDZTVISFpwYUt3X0xzbnBPMlAyQVhTN0U2?oc=5\" target=\"_blank\">Amgen advances toward lupus redemption while gastric cancer candidate struggles</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2026-02-04T11:10:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen resists FDA request to pull rare disease drug Tavneos from the market - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQSTlDdjNlWEJBbE5UZ0Z2NnBQcTk4cXZaUTJTRTdpVGRvZ1MxbTBNUmtUclVXYkV0N2tNSTRWVzZoUTRZU1dVUk1kelNfYzdoYXVlLU5tX3NHbFlwc1hwcmR2QVJSamdNeHhxM2h0Sm1fYlFBNEhwdkdTc2xVVkdmcm9aVHBnT2lZRWpvVExHZWlWbDlJc3cyMkhRWFpDakFuak1v?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxQSTlDdjNlWEJBbE5UZ0Z2NnBQcTk4cXZaUTJTRTdpVGRvZ1MxbTBNUmtUclVXYkV0N2tNSTRWVzZoUTRZU1dVUk1kelNfYzdoYXVlLU5tX3NHbFlwc1hwcmR2QVJSamdNeHhxM2h0Sm1fYlFBNEhwdkdTc2xVVkdmcm9aVHBnT2lZRWpvVExHZWlWbDlJc3cyMkhRWFpDakFuak1v?oc=5\" target=\"_blank\">Amgen resists FDA request to pull rare disease drug Tavneos from the market</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2026-02-04T12:55:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Why Amgen Stock Is Paying Off Big For Long-Term Investors - Forbes",
      "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPLTdFMmV1c1ZwTXJBbU85dXBDM3puX0lRVTJUMU5VU2VmdW9KanlGYkd0aUZjajZHSlpTTURnMDlhSkpGUXdBLS1sVVJPSU9SUS1sWkJ3OGpkekxULWt5eWtKMmhXMVdFWVF4TzdxRks4Q3RUa0JTYXFqZE5mbFh2cGJLaXFDTEk0b1BpT2lWazZNQVdDNVFaYl9VazFnMjF6WFNpYU94UzNvSmhESzI3Y1RIXy1tV2s?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitwFBVV95cUxPLTdFMmV1c1ZwTXJBbU85dXBDM3puX0lRVTJUMU5VU2VmdW9KanlGYkd0aUZjajZHSlpTTURnMDlhSkpGUXdBLS1sVVJPSU9SUS1sWkJ3OGpkekxULWt5eWtKMmhXMVdFWVF4TzdxRks4Q3RUa0JTYXFqZE5mbFh2cGJLaXFDTEk0b1BpT2lWazZNQVdDNVFaYl9VazFnMjF6WFNpYU94UzNvSmhESzI3Y1RIXy1tV2s?oc=5\" target=\"_blank\">Why Amgen Stock Is Paying Off Big For Long-Term Investors</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Forbes</font>",
      "published": "2026-02-04T15:48:28+00:00",
      "source": "Forbes"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNOGRMMXF5YlJsZk83RlJqN3ozY1VjSUlkYnpXX05zZmZCWnRoRHNrTk9IdGVYczVZVk9WTkw0MjNKYmkySWZXOUdDdGFXZWRrRjR6U0VSbmtJbkx6NkQ1bkQycGxEWDlZRVdSTzJidFBabTZLOWxkWnI0WktQMXRNX1lCS04xMmFhV3lrV1BDbGRmRlVhSnBfV1BaMmoyc3hTV3lZOTBRX08tRnRuX0hKTkplc05sN1Q2enYxSDE4X2ZkcFVVU1lENks1VUJHWFZzY2tfOUIxaFBEa1dnRkQw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNOGRMMXF5YlJsZk83RlJqN3ozY1VjSUlkYnpXX05zZmZCWnRoRHNrTk9IdGVYczVZVk9WTkw0MjNKYmkySWZXOUdDdGFXZWRrRjR6U0VSbmtJbkx6NkQ1bkQycGxEWDlZRVdSTzJidFBabTZLOWxkWnI0WktQMXRNX1lCS04xMmFhV3lrV1BDbGRmRlVhSnBfV1BaMmoyc3hTV3lZOTBRX08tRnRuX0hKTkplc05sN1Q2enYxSDE4X2ZkcFVVU1lENks1VUJHWFZzY2tfOUIxaFBEa1dnRkQw?oc=5\" target=\"_blank\">Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2026-02-04T03:18:16+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5\" target=\"_blank\">A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-01T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNLXhOdjVpSkxmUXdQRVpHS2tPVUdGcG1EZHJFZDZpNzg5Y3pCT3FTdlVhNFR4MmhicGVQN0luNnNVMkZCOTF5NkR0WWlUOXVtMmtfbzBJWVE4dUlwbjFXX29sREp3enhLVkowNV9QbXd4UGtMTlJjd29PSHNPSUd3TkhJNm55T1AxRTdUazNkd0NHRThWMGtTZU44V3lidnR5UmQyMWZxd0FrcHVPTVlfWTJWQTFMTGRQRDZQcEtaSlc0TklGNzlMam1pRjhDVVVpc0ZRSg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNLXhOdjVpSkxmUXdQRVpHS2tPVUdGcG1EZHJFZDZpNzg5Y3pCT3FTdlVhNFR4MmhicGVQN0luNnNVMkZCOTF5NkR0WWlUOXVtMmtfbzBJWVE4dUlwbjFXX29sREp3enhLVkowNV9QbXd4UGtMTlJjd29PSHNPSUd3TkhJNm55T1AxRTdUazNkd0NHRThWMGtTZU44V3lidnR5UmQyMWZxd0FrcHVPTVlfWTJWQTFMTGRQRDZQcEtaSlc0TklGNzlMam1pRjhDVVVpc0ZRSg?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-02-06",
      "close": 384.32000732421875
    },
    "history": [
      {
        "date": "2026-01-29",
        "close": 342.94000244140625
      },
      {
        "date": "2026-01-30",
        "close": 341.8800048828125
      },
      {
        "date": "2026-02-02",
        "close": 344.67999267578125
      },
      {
        "date": "2026-02-03",
        "close": 338.5899963378906
      },
      {
        "date": "2026-02-04",
        "close": 366.20001220703125
      },
      {
        "date": "2026-02-05",
        "close": 367.79998779296875
      },
      {
        "date": "2026-02-06",
        "close": 384.32000732421875
      }
    ],
    "name": "Amgen Inc."
  }
}